More on WGS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-85.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GeneDx Holdings (NQ:WGS)
Delayed: 63.61 -6.61 (9.41%)
Prev. Close $70.22  
Open$69.13 
52 Wk High$ 
52 Wk Low$ 
Day High$70.20 
Day Low$62.49 
P/E N/A  
EPS$ 
Volume644,533 

Friends, Peers and Foes (?): GRAL, VRRM, BMI, NAVN, ILMN (more...)

Oct 7, 2026 08:30 AM GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
Oct 2, 2026 08:30 AM GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
Oct 1, 2026 08:48 AM GeneDx (WGS) PT Raised to $83 at Guggenheim
Sep 18, 2026 04:43 PM Form 4 GeneDx Holdings Corp. For: Sep 16 Filed by: Stueland Katherine
Sep 18, 2026 04:39 PM Form 4 GeneDx Holdings Corp. For: Sep 16 Filed by: Feeley Kevin
Sep 18, 2026 04:37 PM Form 4 GeneDx Holdings Corp. For: Sep 17 Filed by: Fuchs Thomas
Sep 11, 2026 04:14 PM Form 4 GeneDx Holdings Corp. For: Sep 09 Filed by: Stueland Katherine
Sep 11, 2026 04:11 PM Form 4 GeneDx Holdings Corp. For: Sep 09 Filed by: Feeley Kevin
Aug 24, 2026 08:34 AM Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's
Aug 24, 2026 08:30 AM GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
View All Articles

Entities mentioned with WGS

View All Entities